Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

393
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
393
Survival Curves01:18

Survival Curves

664
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
664
Restriction Enzymes01:11

Restriction Enzymes

35.6K
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
35.6K
What are Estimates?01:06

What are Estimates?

8.2K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates. 
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
8.2K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

761
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
761
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

570
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
570

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Favorable tolerability of asciminib <i>versus</i> ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia.

Haematologica·2026
Same author

Efficacy of a Moisture-Wicking, Silver-Impregnated Textile in Hospitalized Patients With Intertriginous Dermatitis (ITD): A Single-Case Experiment.

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Corrigendum to "Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials" [Am Heart J 241 (2021) 108-119].

American heart journal·2025
Same author

NLAS-multi: A multilingual corpus of automatically generated Natural Language Argumentation Schemes.

Data in brief·2024
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K

Estimation on conditional restricted mean survival time with counting process.

Junshan Qiu1, Ennan Gu2, Dali Zhou3

  • 1Division of Biometrics I, OB/OTS/CDER, US FDA , Silver Spring , Maryland , USA.

Journal of Biopharmaceutical Statistics
|August 28, 2019
PubMed
Summary
This summary is machine-generated.

Hazard ratio (HR) can be hard to interpret in survival analysis. This study introduces a conditional restricted mean survival time (CRMST) estimator as a more interpretable alternative, validated by simulations and real data.

Keywords:
Restricted mean survival timeproportional hazardsurvival analyses

More Related Videos

Cereal Crop Ear Counting in Field Conditions Using Zenithal RGB Images
11:49

Cereal Crop Ear Counting in Field Conditions Using Zenithal RGB Images

Published on: February 2, 2019

9.8K
Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

3.4K

Related Experiment Videos

Last Updated: Jan 20, 2026

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K
Cereal Crop Ear Counting in Field Conditions Using Zenithal RGB Images
11:49

Cereal Crop Ear Counting in Field Conditions Using Zenithal RGB Images

Published on: February 2, 2019

9.8K
Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

3.4K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Survival Analysis

Background:

  • Traditional survival analyses often rely on hazard ratios (HR) for treatment effect evaluation.
  • HR interpretation can be challenging, especially when the proportional hazards assumption is violated.
  • Restricted mean survival time (RMST) offers a more interpretable alternative to HR.

Purpose of the Study:

  • To develop and validate a conditional restricted mean survival time (CRMST) estimator.
  • To provide a robust method for evaluating treatment effects over a specific time interval.
  • To offer an alternative to HR in survival analysis, particularly when assumptions are not met.

Main Methods:

  • Developed a conditional restricted mean survival time (CRMST) estimator using counting process methodology.
  • Employed a perturbation re-sampling technique to estimate the variance of CRMST, ensuring asymptotic normality.
  • Evaluated the estimator's performance through comprehensive simulation studies and a real-world case study.

Main Results:

  • The developed CRMST estimator demonstrated promising utility in simulation studies.
  • The perturbation re-sampling method provided reliable variance estimation for CRMST.
  • The case study further supported the practical applicability of the CRMST estimator.

Conclusions:

  • Conditional restricted mean survival time (CRMST) is a valuable and interpretable metric in survival analysis.
  • The proposed CRMST estimator offers a robust alternative to traditional hazard ratios.
  • This method shows potential for improved clinical trial interpretation and decision-making.